In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment

D. Stanislaus, X. Yang, J. D. Liang, J. Wolfe, R. L. Cain, J. E. Onyia, N. Falla, P. Marder, Joseph Bidwell, S. W. Queener, J. M. Hock

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Osteoblast differentiation and function can be studied in situ in the metaphysis of growing long bones. Proliferation and apoptosis dominate in the primary spongiosa subjacent to the growth plate, and differentiation and function dominate in the proximal metaphysis. Apoptosis of osteocytes dominates at the termination of the trabeculae in diaphyseal marrow. As parathyroid hormone regulates all phases of osteoblast development, we studied the in vivo regulation by human parathyroid hormone (1-34) (PTH) of apoptosis in bone cells of the distal metaphysis of young male rats. Rats were given PTH at 80 μg/kg per day, once daily, for 1-28 days. Bone cells were defined for flow cytometry as PTH1-receptor-positive (PTH1R+) and growth factor-receptor-positive (GFR+) cells. Apoptotic cells stained positive for either TdT-mediated dUTP-X nick end labeling (TUNEL) or annexin V (annV+) were detected by either flow cytometry or immunohistochemistry. Apoptosis was also assessed at the tissue level by RNAse protection and caspase enzyme activity assays. PTH increased apoptotic osteoblasts in the proliferating zone and apoptotic osteocytes in the terminal trabecular zone, by 40%-60% within 2-6 days of PTH treatment, but values became equivalent to controls after 21-28 days of treatment. This transient increase was confirmed in PTH1R+, GFR+ bone cells isolated by flow cytometry. There was no detectable change in the steady-state mRNA levels of selected apoptotic genes. Starting at 3 days, at the tissue level, PTH inhibited activity of caspases, which recognize the DEVD peptide substrate (caspases 2, 3, and/or 7), but not those caspases recognizing LEHD or YVAD peptide sequences. We speculate that the localized and tissue level effects of PTH on apoptosis can be explained on the basis of its anabolic effect on bone. The transient increase in apoptosis in the proliferating zone and terminal trabecular zone may be the result of the increased activation frequency and bone turnover seen with daily PTH treatment. As once-daily PTH increases the number of differentiated osteoblasts, and as these and hematopoietic marrow cells dominate metaphyseal tissue, inhibition of caspase activity may contribute to their prolonged survival, enabling extension of trabecular bone into the diaphyseal marrow to increase bone mass. Copyright (C) 2000 Elsevier Science Inc.

Original languageEnglish
Pages (from-to)209-218
Number of pages10
JournalBone
Volume27
Issue number2
DOIs
StatePublished - Aug 2000

Fingerprint

Teriparatide
Apoptosis
Caspases
Osteoblasts
Bone and Bones
Osteocytes
Flow Cytometry
Bone Marrow
Caspase 2
Caspase 7
Anabolic Agents
Peptides
Growth Plate
Growth Factor Receptors
Bone Remodeling
Annexin A5
Enzyme Assays
Parathyroid Hormone
Caspase 3
Cancellous Bone

Keywords

  • Apoptosis
  • Caspase enzymes
  • Osteoblasts
  • Osteocytes
  • Parathyroid hormone (PTH)
  • Rats

ASJC Scopus subject areas

  • Physiology
  • Hematology

Cite this

Stanislaus, D., Yang, X., Liang, J. D., Wolfe, J., Cain, R. L., Onyia, J. E., ... Hock, J. M. (2000). In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment. Bone, 27(2), 209-218. https://doi.org/10.1016/S8756-3282(00)00309-4

In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment. / Stanislaus, D.; Yang, X.; Liang, J. D.; Wolfe, J.; Cain, R. L.; Onyia, J. E.; Falla, N.; Marder, P.; Bidwell, Joseph; Queener, S. W.; Hock, J. M.

In: Bone, Vol. 27, No. 2, 08.2000, p. 209-218.

Research output: Contribution to journalArticle

Stanislaus, D, Yang, X, Liang, JD, Wolfe, J, Cain, RL, Onyia, JE, Falla, N, Marder, P, Bidwell, J, Queener, SW & Hock, JM 2000, 'In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment', Bone, vol. 27, no. 2, pp. 209-218. https://doi.org/10.1016/S8756-3282(00)00309-4
Stanislaus, D. ; Yang, X. ; Liang, J. D. ; Wolfe, J. ; Cain, R. L. ; Onyia, J. E. ; Falla, N. ; Marder, P. ; Bidwell, Joseph ; Queener, S. W. ; Hock, J. M. / In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment. In: Bone. 2000 ; Vol. 27, No. 2. pp. 209-218.
@article{815fab3997184294b35430d3e768281e,
title = "In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment",
abstract = "Osteoblast differentiation and function can be studied in situ in the metaphysis of growing long bones. Proliferation and apoptosis dominate in the primary spongiosa subjacent to the growth plate, and differentiation and function dominate in the proximal metaphysis. Apoptosis of osteocytes dominates at the termination of the trabeculae in diaphyseal marrow. As parathyroid hormone regulates all phases of osteoblast development, we studied the in vivo regulation by human parathyroid hormone (1-34) (PTH) of apoptosis in bone cells of the distal metaphysis of young male rats. Rats were given PTH at 80 μg/kg per day, once daily, for 1-28 days. Bone cells were defined for flow cytometry as PTH1-receptor-positive (PTH1R+) and growth factor-receptor-positive (GFR+) cells. Apoptotic cells stained positive for either TdT-mediated dUTP-X nick end labeling (TUNEL) or annexin V (annV+) were detected by either flow cytometry or immunohistochemistry. Apoptosis was also assessed at the tissue level by RNAse protection and caspase enzyme activity assays. PTH increased apoptotic osteoblasts in the proliferating zone and apoptotic osteocytes in the terminal trabecular zone, by 40{\%}-60{\%} within 2-6 days of PTH treatment, but values became equivalent to controls after 21-28 days of treatment. This transient increase was confirmed in PTH1R+, GFR+ bone cells isolated by flow cytometry. There was no detectable change in the steady-state mRNA levels of selected apoptotic genes. Starting at 3 days, at the tissue level, PTH inhibited activity of caspases, which recognize the DEVD peptide substrate (caspases 2, 3, and/or 7), but not those caspases recognizing LEHD or YVAD peptide sequences. We speculate that the localized and tissue level effects of PTH on apoptosis can be explained on the basis of its anabolic effect on bone. The transient increase in apoptosis in the proliferating zone and terminal trabecular zone may be the result of the increased activation frequency and bone turnover seen with daily PTH treatment. As once-daily PTH increases the number of differentiated osteoblasts, and as these and hematopoietic marrow cells dominate metaphyseal tissue, inhibition of caspase activity may contribute to their prolonged survival, enabling extension of trabecular bone into the diaphyseal marrow to increase bone mass. Copyright (C) 2000 Elsevier Science Inc.",
keywords = "Apoptosis, Caspase enzymes, Osteoblasts, Osteocytes, Parathyroid hormone (PTH), Rats",
author = "D. Stanislaus and X. Yang and Liang, {J. D.} and J. Wolfe and Cain, {R. L.} and Onyia, {J. E.} and N. Falla and P. Marder and Joseph Bidwell and Queener, {S. W.} and Hock, {J. M.}",
year = "2000",
month = "8",
doi = "10.1016/S8756-3282(00)00309-4",
language = "English",
volume = "27",
pages = "209--218",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment

AU - Stanislaus, D.

AU - Yang, X.

AU - Liang, J. D.

AU - Wolfe, J.

AU - Cain, R. L.

AU - Onyia, J. E.

AU - Falla, N.

AU - Marder, P.

AU - Bidwell, Joseph

AU - Queener, S. W.

AU - Hock, J. M.

PY - 2000/8

Y1 - 2000/8

N2 - Osteoblast differentiation and function can be studied in situ in the metaphysis of growing long bones. Proliferation and apoptosis dominate in the primary spongiosa subjacent to the growth plate, and differentiation and function dominate in the proximal metaphysis. Apoptosis of osteocytes dominates at the termination of the trabeculae in diaphyseal marrow. As parathyroid hormone regulates all phases of osteoblast development, we studied the in vivo regulation by human parathyroid hormone (1-34) (PTH) of apoptosis in bone cells of the distal metaphysis of young male rats. Rats were given PTH at 80 μg/kg per day, once daily, for 1-28 days. Bone cells were defined for flow cytometry as PTH1-receptor-positive (PTH1R+) and growth factor-receptor-positive (GFR+) cells. Apoptotic cells stained positive for either TdT-mediated dUTP-X nick end labeling (TUNEL) or annexin V (annV+) were detected by either flow cytometry or immunohistochemistry. Apoptosis was also assessed at the tissue level by RNAse protection and caspase enzyme activity assays. PTH increased apoptotic osteoblasts in the proliferating zone and apoptotic osteocytes in the terminal trabecular zone, by 40%-60% within 2-6 days of PTH treatment, but values became equivalent to controls after 21-28 days of treatment. This transient increase was confirmed in PTH1R+, GFR+ bone cells isolated by flow cytometry. There was no detectable change in the steady-state mRNA levels of selected apoptotic genes. Starting at 3 days, at the tissue level, PTH inhibited activity of caspases, which recognize the DEVD peptide substrate (caspases 2, 3, and/or 7), but not those caspases recognizing LEHD or YVAD peptide sequences. We speculate that the localized and tissue level effects of PTH on apoptosis can be explained on the basis of its anabolic effect on bone. The transient increase in apoptosis in the proliferating zone and terminal trabecular zone may be the result of the increased activation frequency and bone turnover seen with daily PTH treatment. As once-daily PTH increases the number of differentiated osteoblasts, and as these and hematopoietic marrow cells dominate metaphyseal tissue, inhibition of caspase activity may contribute to their prolonged survival, enabling extension of trabecular bone into the diaphyseal marrow to increase bone mass. Copyright (C) 2000 Elsevier Science Inc.

AB - Osteoblast differentiation and function can be studied in situ in the metaphysis of growing long bones. Proliferation and apoptosis dominate in the primary spongiosa subjacent to the growth plate, and differentiation and function dominate in the proximal metaphysis. Apoptosis of osteocytes dominates at the termination of the trabeculae in diaphyseal marrow. As parathyroid hormone regulates all phases of osteoblast development, we studied the in vivo regulation by human parathyroid hormone (1-34) (PTH) of apoptosis in bone cells of the distal metaphysis of young male rats. Rats were given PTH at 80 μg/kg per day, once daily, for 1-28 days. Bone cells were defined for flow cytometry as PTH1-receptor-positive (PTH1R+) and growth factor-receptor-positive (GFR+) cells. Apoptotic cells stained positive for either TdT-mediated dUTP-X nick end labeling (TUNEL) or annexin V (annV+) were detected by either flow cytometry or immunohistochemistry. Apoptosis was also assessed at the tissue level by RNAse protection and caspase enzyme activity assays. PTH increased apoptotic osteoblasts in the proliferating zone and apoptotic osteocytes in the terminal trabecular zone, by 40%-60% within 2-6 days of PTH treatment, but values became equivalent to controls after 21-28 days of treatment. This transient increase was confirmed in PTH1R+, GFR+ bone cells isolated by flow cytometry. There was no detectable change in the steady-state mRNA levels of selected apoptotic genes. Starting at 3 days, at the tissue level, PTH inhibited activity of caspases, which recognize the DEVD peptide substrate (caspases 2, 3, and/or 7), but not those caspases recognizing LEHD or YVAD peptide sequences. We speculate that the localized and tissue level effects of PTH on apoptosis can be explained on the basis of its anabolic effect on bone. The transient increase in apoptosis in the proliferating zone and terminal trabecular zone may be the result of the increased activation frequency and bone turnover seen with daily PTH treatment. As once-daily PTH increases the number of differentiated osteoblasts, and as these and hematopoietic marrow cells dominate metaphyseal tissue, inhibition of caspase activity may contribute to their prolonged survival, enabling extension of trabecular bone into the diaphyseal marrow to increase bone mass. Copyright (C) 2000 Elsevier Science Inc.

KW - Apoptosis

KW - Caspase enzymes

KW - Osteoblasts

KW - Osteocytes

KW - Parathyroid hormone (PTH)

KW - Rats

UR - http://www.scopus.com/inward/record.url?scp=18144452145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18144452145&partnerID=8YFLogxK

U2 - 10.1016/S8756-3282(00)00309-4

DO - 10.1016/S8756-3282(00)00309-4

M3 - Article

VL - 27

SP - 209

EP - 218

JO - Bone

JF - Bone

SN - 8756-3282

IS - 2

ER -